Sarcoma: open trials in Hong Kong SAR China

• NCT07541170

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Queen Mary Hospital, Hong Kong · Prince of Wales Hosp, Shatin

  Registry updated 2026-10-13

• NCT06884618

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

  Trial Treatment · Phase 1 · Hoffmann-La Roche

  Prince of Wales Hospital, Hong Kong

  Registry updated 2026-09-28

• NCT07252739

  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Hong Kong Integrated Oncology Centre ( Site 0232), Central · Queen Mary Hospital ( Site 0230), Hong Kong · Hong Kong United Oncology Centre ( Site 0231), Kowloon

  Registry updated 2026-09-02

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Local Institution - 6502, Hong Kong · Local Institution - 6501, Hong Kong

  Registry updated 2026-05-27

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error